NVCT- Nuvectis Pharma, Inc.

Name: Nuvectis Pharma, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Nuvectis Pharma, Inc. (NVCT) has 7 insiders with recent SEC Form 4 filings, including 13 buys and 0 sells. NVCT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Bentsur Ron	3.68M	$71.94M	-
10%	Mosseri Marlio Charles	3.14M	$61.38M	-
Other	Poradosu Enrique	1.81M	$35.35M	-
Other	Shemesh Shay	1.79M	$35.09M	-
VP	Carson Michael J.	200.1K	$3.92M	-

Activity

Buys and sells only

Transactions

10 filings · page 5

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 26, 2023	Bentsur Ron64	Chairman &CEO	Buy	750	$16.50	$12,375.00	-	-16.6%	-56.8%
Jun 26, 2023	Mosseri Marlio Charles46	10% Owner	Buy	16,760	$16.46	$275,869.60	+0.7%	-16.6%	-56.8%
Jun 23, 2023	Mosseri Marlio Charles46	10% Owner	Buy	73,175	$17.43	$1,275,440.25	+3.0%	-19.3%	-58.4%
Jun 22, 2023	Mosseri Marlio Charles46	10% Owner	Buy	13,090	$17.72	$231,963.88	+0.3%	-23.0%	-60.2%
Jun 21, 2023	Bentsur Ron64	Chairman &CEO	Buy	500	$17.88	$8,940.00	-	-19.7%	-61.5%
Jun 16, 2023	Mosseri Marlio Charles46	10% Owner	Buy	12,700	$17.75	$225,425.00	+0.5%	-22.5%	-62.6%
Jun 15, 2023	Mosseri Marlio Charles46	10% Owner	Buy	32,124	$17.71	$568,848.04	+0.7%	-23.6%	-62.8%
Jun 8, 2023	Bentsur Ron64	Chairman &CEO	Buy	350	$17.45	$6,107.90	-	-19.4%	-63.8%
May 31, 2023	Bentsur Ron64	Chairman &CEO	Buy	330	$17.28	$5,702.40	-	-17.0%	-63.4%
May 24, 2023	Bentsur Ron64	Chairman &CEO	Buy	200	$17.49	$3,498.00	-	-14.4%	-61.3%

← PrevPage 5Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC